Raymond James & Associates’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-142,827
Closed -$708K 3957
2024
Q1
$708K Buy
+142,827
New +$914K ﹤0.01% 2834

Other funds holding ALHC

Raymond James & Associates's ALHC Position: Q2 2024 in Review

Raymond James & Associates sold out of Alignment Healthcare (ALHC) in Q2 2024, closing a stake of 142,827 shares — an estimated $708K sold.

Raymond James & Associates first reported a position in ALHC in Q1 2024 and held it in 1 quarter. The position peaked at $708K in Q1 2024. 118 funds tracked by Wall St. Rank hold ALHC as of Q2 2024.

  • Raymond James & Associates reported no remaining Alignment Healthcare position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 142,827 Alignment Healthcare shares in Q2 2024, an estimated $708K.
  • Raymond James & Associates first reported a position in Alignment Healthcare in Q1 2024 and held it in 1 quarter.
  • Raymond James & Associates's Alignment Healthcare position peaked at $708K in Q1 2024.
  • 118 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.